IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,674 | -33.0% | 108,280 | +3.6% | 0.04% | -39.7% |
| Q2 2023 | $735,497 | -33.9% | 104,474 | -42.6% | 0.06% | -40.0% |
| Q1 2023 | $1,112,686 | -4.4% | 182,109 | 0.0% | 0.10% | +18.0% |
| Q4 2022 | $1,163,677 | -30.6% | 182,109 | +4.1% | 0.09% | -29.4% |
| Q3 2022 | $1,677,000 | +1.3% | 175,000 | +16.7% | 0.13% | +10.5% |
| Q2 2022 | $1,656,000 | -0.5% | 150,000 | +50.0% | 0.11% | 0.0% |
| Q1 2022 | $1,665,000 | – | 100,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |